Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07067632

To Study the Mortality Outcome of Controlled Blood Pressure Participants

Mortality Outcome of Controlled Hypertension in Randomized Controlled or Open-label Study Intentionally Directed Intervention Effect Blood Pressure: A Systematic Review and Meta-Analysis

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
DejthidaNathaphong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Despite advances in antihypertensive therapy, some patients with well-controlled blood pressure still experience fatal outcomes. This paradox raises critical questions about the efficacy of blood pressure-targeted interventions and whether BP control alone ensures survival. This systematic review and meta-analysis aims to evaluate all-cause mortality and cardiovascular death among hypertensive patients who achieved BP targets in RCTs or open-label trials. To determine whether achieving controlled blood pressure through intentional intervention (pharmacological or procedural) in RCTs or open-label studies reduces mortality (all-cause and cardiovascular) in hypertensive patients.

Detailed description

Sensitivity Analyses Excluding high-risk of bias studies Excluding short follow-up (\<1 year)

Conditions

Interventions

TypeNameDescription
DRUGAntihypertensive treatmentAny intervention (pharmacological, device-based, lifestyle) intentionally directed at lowering BP Control groups receiving placebo, standard of care, or no intervention

Timeline

Start date
2025-07-01
Primary completion
2026-12-31
Completion
2027-02-01
First posted
2025-07-16
Last updated
2026-04-13

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT07067632. Inclusion in this directory is not an endorsement.